3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
5
Breast
5
Gastrointestinal
4
Tumor-Agnostic
3
Thoracic
3
Sarcoma
2
Dermatologic
2
Gynecologic
1
CNS
1
Conditions
Melanoma
33
Carcinoma, Non-Small-Cell Lung
6
Uveal Melanoma
5
Skin Neoplasms
5
Neoplasms
5
Lymphoma, T-Cell, Cutaneous
4
Kidney Neoplasms
4
Sarcoma
3
Prostatic Neoplasms
3
Mycosis Fungoides
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urticaria Pigmentosa
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Pruritus
1
Pancreatic Neoplasms
1
Interventions
pembrolizumab
36
Cyclophosphamide
24
Nivolumab
23
Ipilimumab
22
aldesleukin
19
Interleukin-2
15
fludarabine
14
Specimen Handling
12
Dacarbazine
11
fludarabine phosphate
10
Magnetic Resonance Spectroscopy
10
Temozolomide
9
Radiosurgery
9
Biopsy
9
cemiplimab
8
Paclitaxel
8
dabrafenib
5
binimetinib
5
Vemurafenib
5
Radiotherapy
5
Carboplatin
5
trametinib
4
sargramostim
4
encorafenib
4
avelumab
4
Pemetrexed
4
Leucovorin
4
Fluorouracil
4
Cisplatin
4
Bevacizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Blood Specimen Collection
×
Dermatologic
×
Clear all
NCT02133222
2026-03-31
AMMAM
Centre Hospitalier Universitaire de Nice
Phase NA
Completed
22 enrolled
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled